SMARCA1 and renal cell carcinoma: However, the majority of RCC GWAS loci reside in non-coding regulatory regions and are postulated to influence RCC risk through dysregulation of gene expression that leads to perturbations of specific cancer pathways, as shown in detailed analysis of loci that are involved in apoptosis, cell growth or SWI/SNF activity8–10.